Q3 2019 ZIOPHARM Oncology Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ziopharm Oncology Third Quarter 2019 Results Call. (Operator Instructions) As a reminder, this call may be recorded.
I would now like to turn the conference over to Mr. Chris Taylor, Vice President of Investor Relations and Corporate Communications. Sir, please go ahead.
Thank you, operator. Good afternoon, and welcome to the Ziopharm Oncology conference call and webcast to review results for the third quarter of 2019. This afternoon, we filed our 10-Q and issued our third quarter news release, both of which are available in the Investor's section of our website, ziopharm.com. For informational purposes, we have also included in our webcast a set of PowerPoint slides to accompany today's commentary. These slides can also be found on our website in the Investor's Section.
During this call, the company will make a number of forward-looking statements, including statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |